Pages that link to "Q73474655"
Jump to navigation
Jump to search
The following pages link to Josep Font (Q73474655):
Displaying 50 items.
- Hepatitis G virus infection in primary Sjögren's syndrome: analysis in a series of 100 patients (Q27477922) (← links)
- HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus (Q28138464) (← links)
- Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis (Q28190493) (← links)
- Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients (Q28195403) (← links)
- Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients (Q28212959) (← links)
- Cardiac toxicity secondary to long term treatment with chloroquine (Q28360029) (← links)
- Calcitriol-mediated hypercalcaemia and increased interleukins in a patient with sarcoid myopathy (Q28368758) (← links)
- Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort (Q31122937) (← links)
- Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort (Q31145074) (← links)
- Circulating soluble adhesion molecules in ANCA-associated vasculitis (Q31832551) (← links)
- Cardiovascular risk factors and the long-term outcome of lupus nephritis (Q31846096) (← links)
- Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients (Q33239982) (← links)
- EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (Q33284736) (← links)
- Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus (Q33329033) (← links)
- Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature (Q33330667) (← links)
- Clinical study and follow-up of 100 patients with the antiphospholipid syndrome (Q33331100) (← links)
- Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE. (Q33331408) (← links)
- Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. (Q33332920) (← links)
- Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome (Q33333384) (← links)
- Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases. (Q33334858) (← links)
- Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients (Q33341941) (← links)
- Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases (Q33346990) (← links)
- Multiorgan thrombotic disorders in systemic lupus erythematosus: a common link? (Q33350163) (← links)
- Systemic lupus erythematosus in men: clinical and immunological characteristics (Q33355187) (← links)
- Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients (Q33357081) (← links)
- Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center (Q33359656) (← links)
- Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases (Q33360085) (← links)
- Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies (Q33360771) (← links)
- Features associated with epilepsy in the antiphospholipid syndrome (Q33361525) (← links)
- Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients (Q33363684) (← links)
- Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients (Q33366327) (← links)
- The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients (Q33371184) (← links)
- The overlap of Sjögren's syndrome with other systemic autoimmune diseases (Q33372729) (← links)
- Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome (Q33373456) (← links)
- Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients (Q33375598) (← links)
- Antiphospholipid antibodies: guidelines for determination (Q33382422) (← links)
- Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients (Q33392824) (← links)
- The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide (Q33401164) (← links)
- Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations (Q33423945) (← links)
- Antiphospholipid antibodies: which ones and when? (Q33430607) (← links)
- Treatment of systemic lupus erythematosus (II) (Q33453253) (← links)
- Primary antiphospholipid syndrome: clinical and biological study of 36 cases (Q33492725) (← links)
- Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome. (Q33499072) (← links)
- Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients (Q33499417) (← links)
- Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients (Q33499605) (← links)
- Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients (Q33500142) (← links)
- Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome? (Q33500378) (← links)
- Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus (Q33501931) (← links)
- Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients (Q33502956) (← links)
- Giant cell arteritis presenting as a supraclavicular nodule (Q33562507) (← links)